BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32611604)

  • 1. NPC1 deficiency impairs cerebellar postnatal development of microglia and climbing fiber refinement in a mouse model of Niemann-Pick disease type C.
    Boyle BR; Melli SE; Altreche RS; Padron ZM; Yousufzai FAK; Kim S; Vasquez MD; Carone DM; Carone BR; Soto I
    Development; 2020 Aug; 147(21):. PubMed ID: 32611604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
    Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
    Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interactions and engulfment of dendrites by microglia precede Purkinje cell degeneration in a mouse model of Niemann Pick Type-C.
    Kavetsky L; Green KK; Boyle BR; Yousufzai FAK; Padron ZM; Melli SE; Kuhnel VL; Jackson HM; Blanco RE; Howell GR; Soto I
    Sci Rep; 2019 Oct; 9(1):14722. PubMed ID: 31605022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The appearance of phagocytic microglia in the postnatal brain of Niemann Pick type C mice is developmentally regulated and underscores shortfalls in fine odor discrimination.
    Rava A; La Rosa P; Palladino G; Dragotto J; Totaro A; Tiberi J; Canterini S; Oddi S; Fiorenza MT
    J Cell Physiol; 2022 Dec; 237(12):4563-4579. PubMed ID: 36322609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C disease.
    Kim S; Ochoa K; Melli SE; Yousufzai FAK; Barrera ZD; Williams AA; McIntyre G; Delgado E; Bolish JN; Macleod CM; Boghos M; Lens HP; Ramos AG; Wilson VB; Maloney K; Padron ZM; Khan AH; Blanco RE; Soto I
    Sci Rep; 2023 Apr; 13(1):5665. PubMed ID: 37024714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
    Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
    Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Cell Transcriptome Analysis of Niemann-Pick Disease, Type C1 Cerebella.
    Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Martin K; Navid F; Iben J; Wassif CA; Cawley NX; Porter FD
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.
    Kodam A; Maulik M; Peake K; Amritraj A; Vetrivel KS; Thinakaran G; Vance JE; Kar S
    Glia; 2010 Aug; 58(11):1267-81. PubMed ID: 20607864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia.
    Colombo A; Dinkel L; Müller SA; Sebastian Monasor L; Schifferer M; Cantuti-Castelvetri L; König J; Vidatic L; Bremova-Ertl T; Lieberman AP; Hecimovic S; Simons M; Lichtenthaler SF; Strupp M; Schneider SA; Tahirovic S
    Nat Commun; 2021 Feb; 12(1):1158. PubMed ID: 33627648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of GABAergic Input Precedes Neurodegeneration of Cerebellar Purkinje Cells of NPC1-Deficient Mice.
    Rabenstein M; Murr N; Hermann A; Rolfs A; Frech MJ
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niemann-Pick Type C1 deficiency in microglia does not cause neuron death in vitro.
    Peake KB; Campenot RB; Vance DE; Vance JE
    Biochim Biophys Acta; 2011 Sep; 1812(9):1121-9. PubMed ID: 21704157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.
    Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP
    Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation.
    Mitroi DN; Pereyra-Gómez G; Soto-Huelin B; Senovilla F; Kobayashi T; Esteban JA; Ledesma MD
    EMBO Rep; 2019 Nov; 20(11):e48143. PubMed ID: 31535451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
    Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
    Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C.
    Chu TT; Tu X; Yang K; Wu J; Repa JJ; Yan N
    Nature; 2021 Aug; 596(7873):570-575. PubMed ID: 34290407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.
    Chung C; Puthanveetil P; Ory DS; Lieberman AP
    Hum Mol Genet; 2016 Apr; 25(7):1434-46. PubMed ID: 26908626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration.
    Elrick MJ; Pacheco CD; Yu T; Dadgar N; Shakkottai VG; Ware C; Paulson HL; Lieberman AP
    Hum Mol Genet; 2010 Mar; 19(5):837-47. PubMed ID: 20007718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention.
    Cougnoux A; Drummond RA; Collar AL; Iben JR; Salman A; Westgarth H; Wassif CA; Cawley NX; Farhat NY; Ozato K; Lionakis MS; Porter FD
    Hum Mol Genet; 2018 Jun; 27(12):2076-2089. PubMed ID: 29617956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C.
    Shin SD; Shin A; Mayagoitia K; Siebold L; Rubini M; Wilson CG; Bellinger DL; Soriano S
    J Neuroinflammation; 2019 Dec; 16(1):269. PubMed ID: 31847862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
    Xie C; Gong XM; Luo J; Li BL; Song BL
    J Lipid Res; 2017 Mar; 58(3):512-518. PubMed ID: 28053186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.